ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,831Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 387

$2.01M Total Retail Price of All Prescriptions

Rank: 5 out of 387

322 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 3,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$228 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 410 195 S3 1 1
PRAVASTATIN SODIUM 256 164 2 15
OMEPRAZOLE 213 93 3 4
LISINOPRIL 194 100 4 3
ZOLPIDEM TARTRATE 170 107 5 16
LEVOTHYROXINE SODIUM 150 96 6 2
TRUVADA 142 0 7 182
NORVIR 139 0 8 205
GABAPENTIN 138 50 9 10
CITALOPRAM HBR 131 65 10 19
ISENTRESS 124 0 11 228
ATENOLOL 123 76 12 20
MIRTAZAPINE 110 11 13 64
ATORVASTATIN CALCIUM 105 79 14 13
SIMVASTATIN 101 85 15 5
AMLODIPINE BESYLATE 98 83 16 6
TRAZODONE HCL 96 46 17 37
WARFARIN SODIUM 90 41 18 17
CYCLOBENZAPRINE HCL 88 22 R 19 42
ATRIPLA 85 0 20 194
FUROSEMIDE 85 58 20 7
LAMIVUDINE-ZIDOVUDINE 83 0 22 289
KALETRA 80 0 23 195
LOSARTAN POTASSIUM 78 63 24 24
SPIRONOLACTONE 76 29 25 67
ALENDRONATE SODIUM 76 60 25 31
GEMFIBROZIL 72 33 27 93
EPZICOM 70 0 28 260
HYDROCHLOROTHIAZIDE 70 46 28 12
REYATAZ 69 0 30 289
PROAIR HFA 69 13 30 47
SUSTIVA 67 0 32 280
METOPROLOL TARTRATE 67 41 32 11
VENTOLIN HFA 66 24 34 142
PLAVIX 66 50 34 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 42 36 30
INTELENCE 63 0 36 267
METFORMIN HCL 62 38 38 8
FLUCONAZOLE 61 0 39 160
AZITHROMYCIN 60 13 40 49
AMITRIPTYLINE HCL 57 0 R 41 62
FLUOXETINE HCL 57 19 41 46
TRAMADOL HCL 56 28 43 14
MORPHINE SULFATE ER 55 18 S2 44 79
NEXIUM 55 0 44 26
ADVAIR DISKUS 54 27 46 41
ALLOPURINOL 53 36 47 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 0 47 90
FINASTERIDE 53 40 47 95
POTASSIUM CHLORIDE 52 37 50 9
SINGULAIR 52 38 50 83
CRESTOR 51 15 52 34
LYRICA 51 27 52 66
BUPROPION HCL SR 50 0 54 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.